Medicus Pharma enters warrant inducement for $3.75M gross; also sells $1.52M shares via SEPA

Medicus Pharma Ltd.

Holder exercises 1.34M existing warrants at $2.80; receives 2.68M new warrants at $3.75 expiring in 5 years.
Gross proceeds from warrant exercise ~$3.75M; net used for clinical trials, working capital, and Antev acquisition costs.
Company sold 490,000 common shares to Yorkville via SEPA for net proceeds of ~$1.52M at ~$3.10/share.
Maxim Group LLC receives 6.0% cash fee on warrant exercise gross proceeds.
Company to file S-1 registration for resale of new warrant shares within 120 days.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.